NAS10029,644+0.67%S&P7,651+0.17%GOLD$4,412−0.30%BTC$81,228−0.01%VIX14.81−4.08%live tape · as of 05:00 UTC
The Screen · Basic Materials · Specialty Chemicals
International Flavors & Fragrances
IFF · a US exchange · USD · Market cap $21.5B · 21,500 employees
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price84.31 USD
Fair value59.65
Ethical score87.9/100
RatingOVERVALUED
Our investment reviews on this name
2026-09-01Read Markup84.28+0.0% to today ✓
2026-08-02Read Distribution79.25+6.4% to today
2026-07-02Read Markup73.01+15.5% to today ✓
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
International Flavors & Fragrances holds its Accumulation at $84.31. The statistical read favours the sellers, held for 13 days.
As held on the ledger · 2026-09-09
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 13 days
Price at the screen
$84.31
Valuation
N/A trailing · 21.31 forward price to earnings
Values screen
PASS· score 87.9
Beta
0.95
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
25.92%
Below 33%
Interest-bearing debt is just 25.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.06%
Below 33%
Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit.
Pass
Receivables
9.09%
Below 49%
Money owed to the company is 9.1% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades above our $59.65 fair value estimate, narrow competitive moat, 1.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 29.2% above the base estimate.
Third-party analyst targets: 18 covering, consensus Buy. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Premium Price for Shrinking Scent Sales
Every time you open a bottle of perfume or sip a flavoured drink, the ingredients likely trace back to IFF's factories. Yet the shares trade at a 16 percent premium to our fair value, with revenue already sliding 4 percent and margins stuck at 8 percent.
The narrow moat and 6 percent return on equity do not justify a 16.3 times forward multiple when growth has turned negative. In a cyclical business like specialty chemicals, that earnings multiple often signals peak profits rather than a bargain, even with the consensus buy rating from analysts.
Currency swings and demand swings in consumer products remain real threats, and low returns leave little cushion if volumes keep falling. The ethical screen clears, but the valuation gap still looks wide.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
IFF trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-01Markup · changed$84.28+6.3%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (17 analysts) rates it buy, with a mean price target of $92.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (17 analysts) rates it buy, with a mean price target of $92.
2026-07-18Markup$73.01+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (17 analysts) rates it buy, with a mean price target of $92.
2026-07-03Markup$73.01+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$73.01Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
